Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes

Citations Over TimeTop 1% of 2010 papers

Abstract

As part of our effort to increase survival of drug candidates and to move our medicinal chemistry design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) molecules. We carried out a thorough analysis of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates. In particular, we focused on understanding the relationships between physicochemical properties, in vitro ADME (absorption, distribution, metabolism, and elimination) attributes, primary pharmacology binding efficiencies, and in vitro safety data for these two sets of compounds. This scholarship provides guidance for the design of CNS molecules in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.

Related Papers

• → The emerging importance of predictive ADME simulation in drug discovery(2002)236 cited
• → ADME–Tox in drug discovery: integration of experimental and computational technologies(2003)181 cited
• → Applications of high-throughput ADME in drug discovery(2004)149 cited
• → ADME Optimization and Toxicity Assessment in Early- and Late-Phase Drug Discovery(2009)83 cited
• → Advantages of Good Drug-like Properties(2008)18 cited